Marker for prognosis of a clinical outcome of an autologous intervertebral disc cell transplantation, for progress assessment/progress monitoring of an autologous intervertebral disc cell transplantation, for assessing the quality of intervertebral disc cells, for assessing the quality of an implant and/or medication for novel therapies (ATMP) for the treatment of an intervertebral disc defect, and for diagnosis of an intervertebral and/or spinal column defect
The invention relates to markers for use in vitro in the prediction (prognosis) of a clinical outcome (so-called outcome prognosis) of an autologous intervertebral disc cell transplantation, in particular a matrix-associated autologous intervertebral disc cell transplantation, and/or progress assessment/progress monitoring of an autologous intervertebral disc cell transplantation, in particular a matrix-associated autologous intervertebral disc cell transplantation, and/or in the assessment of the quality of intervertebral disc cells, preferably for an autologous intervertebral disc cell transplantation, in particular for a matrix-associated autologous intervertebral disc cell transplantation, and/or in the assessment of quality of an implant and/or a medication for novel therapies (ATMP) for the treatment of an intervertebral disc defect and/or for the reconstruction of intervertebral disc tissue and/or in the diagnosis of an intervertebral disc defect, in particular a lumbar, preferably lumbar-sacral interv
